| Medical and Health Sciences | Lifetime | 328 | US 182 | 99.99 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 28 | US 15 | 99.90 |
| Cardiology and Cardiovascular Medicine | Lifetime | 80 | US 44 | 99.93 |
| Gender Studies | Lifetime | 387 | US 240 | 98.20 |
| Complementary and Alternative Medicine | Lifetime | 434 | US 153 | 97.44 |
| Emergency Medicine | Lifetime | 782 | US 420 | 91.33 |
| Critical Care and Intensive Care Medicine | Lifetime | 440 | US 188 | 89.37 |
| Gender Studies | 2021-2025 | 63 | US 25 | 97.67 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 152 | US 53 | 97.14 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 281 | US 133 | 97.64 |
| Emergency Medicine | 2021-2025 | 107 | US 46 | 94.74 |
| General Health Professions | 2021-2025 | 875 | US 302 | 92.71 |
| Cardiac Imaging and Diagnostics | Lifetime | 15 | US 11 | 99.96 |
| Cardiovascular Function and Risk Factors | Lifetime | 22 | US 16 | 99.93 |
| Diversity and Career in Medicine | Lifetime | 11 | US 8 | 99.44 |
| Cardiac Valve Diseases and Treatments | Lifetime | 56 | US 35 | 99.85 |
| Cardiovascular Effects of Exercise | Lifetime | 24 | US 11 | 99.73 |
| Radiation Dose and Imaging | Lifetime | 35 | US 23 | 99.53 |
| Ultrasound in Clinical Applications | Lifetime | 26 | US 11 | 99.28 |
| Acute Myocardial Infarction Research | Lifetime | 105 | US 64 | 99.65 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 124 | US 66 | 99.42 |
| Coronary Interventions and Diagnostics | Lifetime | 162 | US 81 | 99.47 |
| Advanced X-ray and CT Imaging | Lifetime | 153 | US 74 | 98.98 |
| Cardiovascular Disease and Adiposity | Lifetime | 159 | US 91 | 99.12 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 71 | US 41 | 98.22 |
| Sex and Gender in Healthcare | Lifetime | 21 | US 16 | 97.60 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 894 | US 452 | 98.35 |
| Cardiovascular and exercise physiology | Lifetime | 352 | US 137 | 98.40 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 903 | US 350 | 97.96 |
| Cardiomyopathy and Myosin Studies | Lifetime | 603 | US 301 | 97.09 |
| Health and Medical Research Impacts | Lifetime | 391 | US 229 | 92.78 |
| HIV-related health complications and treatments | Lifetime | 687 | US 374 | 95.19 |
| Medical Education and Admissions | Lifetime | 335 | US 200 | 92.79 |
| Cardiac Fibrosis and Remodeling | Lifetime | 715 | US 260 | 91.81 |
| Cardiovascular Health and Risk Factors | Lifetime | 970 | US 486 | 89.41 |
| Healthcare Systems and Challenges | Lifetime | 854 | US 151 | 62.09 |
| Diversity and Career in Medicine | 2021-2025 | 17 | US 17 | 98.59 |
| HIV-related health complications and treatments | 2021-2025 | 21 | US 11 | 98.19 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 124 | US 44 | 98.87 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 57 | US 20 | 96.87 |
| Acute Myocardial Infarction Research | 2021-2025 | 320 | US 79 | 95.88 |
| Coronary Interventions and Diagnostics | 2021-2025 | 578 | US 122 | 93.85 |
| Health and Medical Research Impacts | 2021-2025 | 124 | US 68 | 87.48 |
| Radiation Dose and Imaging | 2021-2025 | 576 | US 155 | 88.67 |
| Healthcare professionals’ stress and burnout | 2021-2025 | 751 | US 160 | 84.24 |
| HIV/AIDS drug development and treatment | 2021-2025 | 746 | US 244 | 84.50 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 606 | US 288 | 82.17 |
| Medical Education and Admissions | 2021-2025 | 244 | US 172 | 79.15 |
| Global Health Workforce Issues | 2021-2025 | 607 | US 225 | 77.76 |
| Sex and Gender in Healthcare | 2021-2025 | 241 | US 93 | 70.17 |
| Workplace Violence and Bullying | 2021-2025 | 570 | US 99 | 55.03 |
| Aortic Thrombus and Embolism | 2021-2025 | 163 | US 44 | 45.46 |
| Health and Conflict Studies | 2021-2025 | 844 | US 203 | 30.00 |
